Global Med Technologies(R) to Present at Noble Financial Group Two Double-0-Seven Small Cap Equity Conference
August 14 2007 - 9:00AM
PR Newswire (US)
DENVER, Aug. 14 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
will present at the Noble Financial Equity Conference to be held
August 20-21 at the Charleston Place Hotel in Charleston, South
Carolina. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) On
Monday, August 20, at 10:00 a.m., Global Med's management will give
a 25-minute presentation regarding Global Med's business and
discuss its unique value proposition, latest developments,
financial performance and prospects. Management will also
participate in a question and answer session following the
presentation and in one-on-one meetings throughout the day. The
presentation, with streaming video and PowerPoint presentation,
will be webcast live and archived on the websites of Global Med
(http://www.globalmedtech.com/), and at Noble Financial's
conference website at http://www.two-007.net/. It is recommended
that interested parties register at least 15 minutes prior to the
start of the presentation to ensure timely access. About Noble
Financial Noble Financial is a privately-held, full-service capital
markets firm driven by what is often overlooked by other firms --
uncovering the value embedded in the orphaned, undiscovered or
misunderstood company. The company focuses on converting market
inefficiencies into profit opportunities. Noble Financial supports
emerging companies through strategic advice, investment banking,
market-making, sales and trading, comprehensive equity research,
and the development of institutional support. This is Noble
Financial's third equity conference. The company has operated for
23 years and has offices in Florida and New York City. About Global
Med Technologies, Inc. Global Med Technologies(R), Inc. is an
international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies(R) division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are also being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the Donor Doc(TM) interactive donor health history
questionnaire, SafeTrace(R) donor management system, and the
SafeTrace Tx(R) advanced transfusion management system, recently
patented, provide Vein-to-Vein(R) tracking from donor collection to
patient transfusion. For more information about Global Med's
products and services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Investors, Paul Holm, , or H.L. Lanzet, both for
Global Med, +1-212-888-4570, or Michael I. Ruxin, M.D., Global Med
Technologies, Inc., +1-303-238-2000 Web site:
http://www.globalmedtech.com/ http://www.two-007.net/
Copyright